Posted by: Audrey Erbes | October 27, 2008

Wow! What a Lineup of Meetings Through End of November

Wow! What a lineup of meetings several of which are free but also many in midrange from $10 to $25. There are those with full dinner which are pricier and some local stellar intensive UC extension courses (see some UCB Ext. mentions–” I’m  Macys sending you to Gimbels” a la Miracle on 34th Street). The latter are geared to our Bay Area life science company needs and are reasonable compared to pricing of for-profit courses developed on East Coast that run from $1,500 to $2,700 for 2-3 days.

I’ve seen Julie Tompkins’ presentation for tomorrow morning’s Bio2Device Group meeting–this has some of the latest role and impact of the patient on our products,  industry and marketing tactics. Hope to see you there.

We welcome back BioE2E on Nov. 5th  after their extended summer vacation and will have had two BayBio breakfasts–medtech and therapeutic drugs, respectively–this month. There are some Saturday events for those who can’t get to the day or evening events. And many, many more to suit all your tastes and interests. These gatherings are especially important in keeping your network contacts live and growing during these trying times.

Hope to see you soon. I’ve pasted in the downloadable list below my blurb trailer regarding my upcoming Bio Biz dev course.

Don’t forget to check out the UCSC Extension listings at for applied learning for industry professionals. My next Bioscience Business Development : Building Value course is Dec. 11-12th. Once again we expect to offer a 2-month complementary access to BioCentury Archives and  web hosted subscription databases to use for researching and writing your business plan or in depth opportunity assessment term paper. What a generous offer from these premier local companies to help our working professionals access information needed to develop their papers. Sign up prior to Nov. 27th and also get a deep discount for the course. See Topics and speakers include:


Audrey Erbes, Ph.D., is a marketing professional with more than 25 years of managerial experience in marketing and business development in the biotech and pharmaceutical industries. She was Executive VP and cofounder of Kowa Research Institute, a biopharmaceutical licensing and investment subsidiary of Kowa Company Ltd., Japan. Previously, she held man­agement positions at Syntex Corp. in market research, product management, strategic marketing and planning, and business development in the U.S. and abroad, with a special emphasis on Europe and Asia/Pacific/Canada. Topic: “Business Development in the Bioscience Industry”

Gilbert R. Mintz, Ph.D., is president of GRM Associates, a biotechnology consulting firm with expertise in business development, licensing and strategic planning. With more than 20 years in the biotechnology industry, Dr. Mintz has held corporate management and executive-level business development positions at Genelabs Technologies, Anergen (Corixa), and Cygnus. He has executed technology-platform, corporate and academic collaborations and in/out licensing of late-stage products for partnerships in the U.S., Europe and Japan for such companies as Affymetrix, Aclara and Biota Inc.
Topic: “Working Your Way Through the Bioscience Licensing Process: Licensing – The Process and Transaction”

Guest Speakers:
Ginger Dreger, J.D., M.S., partner in Goodwin Proctor’s Business Law Department and member of its Technology Companies and Intellectual Property Groups in its Palo Altooffice. Prior to joining Goodwin Procter, Ginger headed the biotechnology patent prosecution group in the Silicon Valleyoffice of Heller Ehrman.Topic: “Biotech IP Life Cycle Planning: U.S. and International Patent Issues” Harold (Hal) Etterman, M.B.A., has over 25 years of experience in Finance, Operations and Information Technology, including over ten years serving as a CFO, COO and interim CEO. Hal supports early-stage technology businesses in formulating business strategies, venture funding and the development of strategic alliances. Topic:  “Financial Planning and Funding for a Bioscience Venture: New, Emerging and Growing Entities”

Carolyn Feamster, M.B.A., a business strategy and analysis consultant, has over 25 years of experience in the pharmaceutical and biotech arenas including therapeutics, diagnostics and drug delivery systems. She has broad expertise across numerous therapeutic areas and has held positions at Syntex, ALZA, Corixa Corporation, and Clearview Projects, where she was most recently vice president of business strategy and analysis. Topic: “Preparing for and Planning Deals for Maximum Strategic Impact”

Michael G. McCully, M.S. as a Director at Recombinant Capital (Recap), consults on deal structuring and valuation for Recap Consulting clients and focuses on top-level analyses of business development activity in the biotech and pharmaceutical industry with top tier pharmaceutical firms, investment concerns, and over thirty biotech companies, ranging from early stage platform companies to late stage drug developers. Prior to Recap, Mike worked with Burrill & Company evaluating investment opportunities for the firm’s venture funds and developing strategies for investments in the diagnostic space. Topic: “Biotech Business Development: Where Do We Go From Here”

Herwig von Morze, Ph.D., is an international patent consultant with 27 years of corporate patent experience in Europe and the United States. He spent 8 years (1995-2003) at Heller Ehrman, where he assisted clients in designing the most effective international patent strategy. He has extensive experience in international patent strategy, prosecution, appeal, opposition and patent term extension practice and international patent litigation. He established his own international patent practice in 2004. Topic: “Biotech IP Life Cycle Planning: U.S. and International Patent Issues”


Have some fun on Halloween, too.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s


%d bloggers like this: